<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
   xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
   xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
   xmlns="http://purl.org/rss/1.0/"
   xmlns:dc="http://purl.org/dc/elements/1.1/"
   xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
   xmlns:dcterms="http://purl.org/dc/terms/"

>
<channel rdf:about="http://www.citeulike.org/about">
<pubDate>Sun, 27 Jul 2008 06:06:33 BST</pubDate>


	<title>CiteULike: AlfonsoVicenteSuarez's tlrs-lymphocytes</title>
	<description>CiteULike: AlfonsoVicenteSuarez's tlrs-lymphocytes</description>


	<link>http://www.citeulike.org/user/AlfonsoVicenteSuarez/tag/tlrs-lymphocytes</link>
	<dc:publisher>CiteULike.org</dc:publisher>
	<dc:language>en-gb</dc:language>
	<dc:rights>Copyright &#169; 2004-2008 citeulike.org</dc:rights>
	<items>
    <rdf:Seq>
        <rdf:li rdf:resource="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1382216"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1382197"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1378916"/>

	</rdf:Seq>
	</items>
	</channel>


<item rdf:about="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1382216">
    <title>Regulatory T Cells Selectively Express Toll-like Receptors and Are Activated by Lipopolysaccharide</title>
    <link>http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1382216</link>
    <description>&lt;i&gt;J. Exp. Med., Vol. 197, No. 4. (17 February 2003), pp. 403-411.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Regulatory CD4 T cells (Treg) control inflammatory reactions to commensal bacteria and opportunist pathogens. Activation of Treg functions during these processes might be mediated by host-derived proinflammatory molecules or directly by bacterial products. We tested the hypothesis that engagement of germline-encoded receptors expressed by Treg participate in the triggering of their function. We report that the subset of CD4 cells known to exert regulatory functions in vivo (CD45RBlow CD25+) selectively express Toll-like receptors (TLR)-4, -5, -7, and -8. Exposure of CD4+ CD25+ cells to the TLR-4 ligand lipopolysaccharide (LPS) induces up-regulation of several activation markers and enhances their survival/proliferation. This proliferative response does not require antigen-presenting cells and is augmented by T cell receptor triggering and interleukin 2 stimulation. Most importantly, LPS treatment increases CD4+ CD25+ cell suppressor efficiency by 10-fold and reveals suppressive activity in the CD4+ CD45RBlow CD25- subset that when tested ex-vivo, scores negative. Moreover, LPS-activated Treg efficiently control naive CD4 T cell-dependent wasting disease. These findings provide the first evidence that Treg respond directly to proinflammatory bacterial products, a mechanism that likely contributes to the control of inflammatory responses. 10.1084/jem.20021633</description>
    <dc:title>Regulatory T Cells Selectively Express Toll-like Receptors and Are Activated by Lipopolysaccharide</dc:title>

    <dc:creator>Iris Caramalho</dc:creator>
    <dc:creator>Thiago Lopes-Carvalho</dc:creator>
    <dc:creator>Dominique Ostler</dc:creator>
    <dc:creator>Santiago Zelenay</dc:creator>
    <dc:creator>Matthias Haury</dc:creator>
    <dc:creator>Jocelyne Demengeot</dc:creator>
    <dc:identifier>doi:10.1084/jem.20021633</dc:identifier>
    <dc:source>J. Exp. Med., Vol. 197, No. 4. (17 February 2003), pp. 403-411.</dc:source>
    <dc:date>2007-06-12T21:34:17-00:00</dc:date>
    <prism:publicationYear>2003</prism:publicationYear>
    <prism:publicationName>J. Exp. Med.</prism:publicationName>
    <prism:volume>197</prism:volume>
    <prism:number>4</prism:number>
    <prism:startingPage>403</prism:startingPage>
    <prism:endingPage>411</prism:endingPage>
    <prism:category>tlr5-flagellin</prism:category>
    <prism:category>tlrs-lymphocytes</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1382197">
    <title>Direct Stimulation of Human T Cells via TLR5 and TLR7/8: Flagellin and R-848 Up-Regulate Proliferation and IFN-gamma Production by Memory CD4+ T Cells</title>
    <link>http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1382197</link>
    <description>&lt;i&gt;J Immunol, Vol. 175, No. 3. (1 August 2005), pp. 1551-1557.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;TLRs are involved in innate cell activation by conserved structures expressed by microorganisms. Human T cells express the mRNA encoding most of TLRs. Therefore, we tested whether some TLR ligands may modulate the function of highly purified human CD4+ T lymphocytes. We report that, in the absence of APCs, flagellin (a TLR5 ligand) and R-848 (a TLR7/8 ligand) synergized with suboptimal concentrations of TCR-dependent (anti-CD3 mAb) or -independent stimuli (anti-CD2 mAbs or IL-2) to up-regulate proliferation and IFN-gamma, IL-8, and IL-10 but not IL-4 production by human CD4+ T cells. No effect of poly(I:C) and LPS, ligands for TLR3 and TLR4, respectively, was detected. We also observed that CD4+CD45RO+ memory T cell responses to TLR ligands were more potent than those observed with CD4+CD45RA+ naive T cells. Moreover, among the memory T cells, CCR7- effector cells were more sensitive to TLR ligands than CCR7+ central memory cells. These data demonstrate for the first time a direct effect of TLR5 and TLR7/8 ligands on human T cells, and highlight an innate arm in T cell functions. They also suggest that some components from invading microorganisms may directly stimulate effector memory T cells located in tissues by up-regulating cytokine and chemokine production.</description>
    <dc:title>Direct Stimulation of Human T Cells via TLR5 and TLR7/8: Flagellin and R-848 Up-Regulate Proliferation and IFN-gamma Production by Memory CD4+ T Cells</dc:title>

    <dc:creator>Gersende Caron</dc:creator>
    <dc:creator>Dorothee Duluc</dc:creator>
    <dc:creator>Isabelle Fremaux</dc:creator>
    <dc:creator>Pascale Jeannin</dc:creator>
    <dc:creator>Catherine David</dc:creator>
    <dc:creator>Hugues Gascan</dc:creator>
    <dc:creator>Yves Delneste</dc:creator>
    <dc:source>J Immunol, Vol. 175, No. 3. (1 August 2005), pp. 1551-1557.</dc:source>
    <dc:date>2007-06-12T21:12:38-00:00</dc:date>
    <prism:publicationYear>2005</prism:publicationYear>
    <prism:publicationName>J Immunol</prism:publicationName>
    <prism:volume>175</prism:volume>
    <prism:number>3</prism:number>
    <prism:startingPage>1551</prism:startingPage>
    <prism:endingPage>1557</prism:endingPage>
    <prism:category>tlr5-flagellin</prism:category>
    <prism:category>tlrs-lymphocytes</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1378916">
    <title>Expression and function of Toll-like receptors in T lymphocytes</title>
    <link>http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1378916</link>
    <description>&lt;i&gt;Current Opinion in Immunology, Vol. 19, No. 1. (February 2007), pp. 39-45.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Toll-like receptors (TLRs) are widely expressed in the innate immune system. They recognize conserved microbial ligands such as bacterial lipopolysaccharide, lipopeptides or viral and bacterial RNA and DNA. TLRs play an essential role in innate immune responses and in the initiation of adaptive immune responses. However, certain TLRs are also expressed in T lymphocytes, and the respective ligands can directly modulate T cell function. TLR2, TLR3, TLR5 and TLR9 act as co-stimulatory receptors to enhance proliferation and/or cytokine production of T-cell receptor-stimulated T lymphocytes. In addition, TLR2, TLR5 and TLR8 modulate the suppressive activity of naturally occurring CD25+CD4+ regulatory T cells. The direct responsiveness of T lymphocytes to TLR ligands offers new perspectives for the immunotherapeutic manipulation of T cell responses.</description>
    <dc:title>Expression and function of Toll-like receptors in T lymphocytes</dc:title>

    <dc:creator>Dieter Kabelitz</dc:creator>
    <dc:source>Current Opinion in Immunology, Vol. 19, No. 1. (February 2007), pp. 39-45.</dc:source>
    <dc:date>2007-06-11T15:54:42-00:00</dc:date>
    <prism:publicationYear>2007</prism:publicationYear>
    <prism:publicationName>Current Opinion in Immunology</prism:publicationName>
    <prism:volume>19</prism:volume>
    <prism:number>1</prism:number>
    <prism:startingPage>39</prism:startingPage>
    <prism:endingPage>45</prism:endingPage>
    <prism:category>tlrs-lymphocytes</prism:category>
</item>



</rdf:RDF>

